Lupus nephritis complicated with malignant hypertension: From renal vascular pathology to clinical relevance

Chinese Medical Sciences Journal

Volumn 23, Issue 2, 2008, Pages 81-87

  Tao, Jian Ling ^a   Li, Hang ^a   Tang, Yu ^a   Wen, Yu Bing ^a   Li, Xue Wang ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Lupus nephritis; Malignant hypertension; Renal pathology; Renal vascular involvement; Thrombotic microangiopathy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTINUCLEAR ANTIBODY; COMPLEMENT; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADOLESCENT; ADULT; ARTERIOSCLEROSIS; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; FEMALE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MALIGNANT HYPERTENSION; PLASMAPHERESIS; RENOVASCULAR DISEASE; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR DISEASE;

EID: 47349122455     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-9294(09)60017-1     Document Type: Article

References (14)

1. Kitiyakara C, Guzman NJ. Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol 1998; 9:133-42.
2. Weening JJ, D'Agati VD, Schwartz MM, et al. Classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65:521-30.
3. Hawker G, Gabriel S, Bombardier C, et al. A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. J Rheumatol 1993; 20:657-60.
4. Descombes E, Droz D. Renal vascular lesions in lupus nephritis. Medicine 1997; 76:355-65.
5. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42:1309-11.
6. Nochy D, Daugas E, Droz D, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephro 1999; 10:507-18.
7. Daugas E, Nochy D, Huong D, et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 2002; 13:42-52.
8. Du Y, Li YJ, Yang NS, et al. The risk factors of hypertension in 729 patients with lupus nephritis. Chin J Rheu 2005; 9:169-72.
9. Naiker IP, Chrystal V, Randeree IG, et al. The significance of arterial hypertension at the onset of clinical lupus nephritis. Postgrad Med J 1997; 73:230-3.
10. Markowitz GS, D'Agati VD. The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years. Kidney Int 2007; 71:491-5.
11. Yao G, Hu WX, Liu ZH, et al. The significance of renal vascular lesion in patients with proliferative lupus nephritis. Chin J Nephrol Dia Trans 2002; 11:211-7.
12. Banfi G, Bertani T, Boeri V, et al. Renal vascular lesions as a marker of a poor prognosis in patients with lupus nephritis. Am J Kidney Dis 1991; 18:240-52.
13. Hughson MD, Nadasdy T, McCarty GA, et al. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis 1992; 20: 150-8.
14. Charney DA, Nassar G, Truong L, et al. "Pauci-Immune" proliferative and necrotizing glomerulonephritis with thrombotic microangiopathy in patients with systemic lupus erythematosus and lupus-like syndrome. Am J Kidney Dis 2000; 35:1193-9.